(86 days)
Not Found
Not Found
No
The device description and performance studies focus on the biological properties and function of Bovine Serum Albumin as a protein supplement, with no mention of AI or ML technologies.
No.
The BSA described is a protein supplement used during assisted reproductive procedures, primarily for in vitro fertilization, embryo culture, and cryopreservation. It supports embryonic growth but does not directly treat a disease or condition in a patient.
No
The device is a protein supplement used in assisted reproductive procedures (IVF, embryo culture, cryopreservation) and does not perform diagnostic functions.
No
The device description clearly states it is a solution or powder, which are physical substances, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes the use of Bovine Serum Albumin as a protein supplement in assisted reproductive procedures like in vitro fertilization, embryo culture, and cryopreservation. These are procedures performed outside the human body, but the BSA itself is a component used in the culture media or solutions, not a test performed on a specimen from the human body to provide diagnostic information.
- Device Description: The description details the composition of the BSA solution or powder. This aligns with a reagent or component used in a laboratory procedure, not a diagnostic test kit or instrument.
- Lack of Diagnostic Purpose: The information does not mention any intent to diagnose a disease, condition, or state of health. The purpose is to support the viability and development of gametes and embryos.
- Performance Studies: The performance study described is a mouse embryo assay to assess functionality and lack of toxicity, which is relevant to the quality of the reagent for its intended use in culture, not a clinical performance study for a diagnostic test.
- Predicate Device: The predicate device mentioned is a "Notice of Final Rule," which likely relates to the regulation of these types of products, not a specific IVD predicate device.
IVDs are typically used to examine specimens (like blood, urine, tissue) from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This BSA product does not fit that description. It is a reagent used in a laboratory procedure.
N/A
Intended Use / Indications for Use
Bovine Serum Albumin is intended for use in assisted reproductive procedures that require protein supplementation. These procedures include in vitro fertilization, embryo culture and growth.
Bovine Serum Albumin ((BSA) is intended for those assisted reproductive procedures that require the use of a protein supplement. In particular, BSA is intended for use during in vitro fertilization, during in vitro embryo culture to the desired stage of embryo development, and for the cryopreservation of human embryos.
Product codes (comma separated list FDA assigned to the subject device)
85 MQL
Device Description
Bovine Serum Albumin, Fraction V 10% solution consists of Bovine Serum Albumin from United States source animals (10mg/mL) in a sterile saline solution. Bovine Serum Albumin, Fraction V Powder consists of BSA from United States source animals.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
BSA is assayed by mouse embryo assay prior to release to market. This assay assures that the product is both functional for its intended use, the support of embryonic growth, and that no toxic components are present in the formulation. Bovine Serum Albumin has been used in a variety of clinical settings, for their intended use, for a number of years. In that time, the product has become one of the standard protein supplements used for the in vitro fertilization and growth of human gametes and embryos.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Notice of Final Rule, 63 FR 48428, Docket number 97N-0335
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 884.6180 Reproductive media and supplements.
(a)
Identification. Reproductive media and supplement are products that are used for assisted reproduction procedures. Media include liquid and powder versions of various substances that come in direct physical contact with human gametes or embryos (including water, acid solutions used to treat gametes or embryos, rinsing solutions, sperm separation media, supplements, or oil used to cover the media) for the purposes of preparation, maintenance, transfer or storage. Supplements are specific reagents added to media to enhance specific properties of the media (e.g., proteins, sera, antibiotics, etc.).(b)
Classification. Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, biocompatibility testing, and clinical testing). The device, when it is phosphate-buffered saline used for washing, and short-term handling and manipulation of gametes and embryos; culture oil used as an overlay for culture media containing gametes and embryos; and water for assisted reproduction applications, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.
0
Irvine Scientific
JE 491338 14 1939
Image /page/0/Picture/3 description: The image is a black and white graphic of an abstract design. The design features a bold, black square outline with a white interior space. Inside the white space, there are thick, black lines forming an abstract shape, possibly resembling a stylized letter or symbol. The lines are geometric and angular, creating a modern and minimalist aesthetic.
IRVINE SCIENTIFIC
510(k) SUMMARY AS REQUIRED BY SECTION 807.92(c)
Submitted by:
Irvine Scientific Sales Co., Inc. 2511 Daimler Street Santa Ana, CA 92705-5588
Telephone: (800) 437-5706 Facsimile: (949) 261-6522
Contact: Roberta L. Johnson
Date Submitted: April 16, 1999
Device Identification:
| Trade Name: | Bovine Serum Albumin (BSA) |
|---|---|
| Common Name: | Protein supplement for in vitro embryo culture |
| Classification Name: | Reproductive Media (21 CFR, 886.6180) |
Predicate Device:
Notice of Final Rule, 63 FR 48428, Docket number 97N-0335
Description:
Bovine Serum Albumin, Fraction V 10% solution consists of Bovine Serum Albumin from United States source animals (10mg/mL) in a sterile saline solution. Bovine Serum Albumin, Fraction V Powder consists of BSA from United States source animals.
Bovine Serum Albumin (BSA)
2511 Daimler Street · Santa Ana, CA · 927055588 · 949-261-7800 · 800-437-5706 · FAX: 949-261-6522 · http://www.ci.com
1
Intended Use:
Bovine Serum Albumin is intended for use in assisted reproductive procedures that require protein supplementation. These procedures include in vitro fertilization, embryo culture and growth.
Technological Characteristics:
Depending upon the procedure used, an appropriate amount of pre-warmed, equilibrated BSA is withdrawn, and added to the culture dish and support medium. After the desired stage of embryo development is achieved, the embryo is removed from the culture dish, placed into a HEPES-buffered transfer medium, and implanted into the patient. BSA is not intended to contact the patient.
Performance Data:
BSA is assayed by mouse embryo assay prior to release to market. This assay assures that the product is both functional for its intended use, the support of embryonic growth, and that no toxic components are present in the formulation. Bovine Serum Albumin has been used in a variety of clinical settings, for their intended use, for a number of years. In that time, the product has become one of the standard protein supplements used for the in vitro fertilization and growth of human gametes and embryos.
Additional Information:
Mouse embryo testing will be performed as a condition of release for this product, as well as endotoxin and sterility testing. Results of all release assays performed will be reported on a lot-specific certificate of analysis, and will be indicated on the labeling.
2
Conclusion:
The conclusion from performance testing, as well as a review of the historical information contained in professional literature shows that Bovine Serum Albumin is suitable for its intended use, and meet the criteria outlined in the Notice of Final Rule, 63 FR 48428, Docket number 97N-0335.
3
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 4 1999
Ms. Roberta L. Johnson Manager, Regulatory Affairs Irvine Scientific. Inc. 2511 Daimler Road Santa Ana, CA 92705-5588 Re: K991338 Bovine Serum Albumin (BSA) Dated: April 16, 1999 Received: April 19, 1999 Requlatory Class: II 21 CFR §884.6180/Procode: 85 MQL
Dear Ms. Johnson:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
CAPT Daniel G. Schultz, M.D. Acting Director. Division of Reproductive. Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Irvine Scientific
INDICATIONS FOR USE STATEMENT (page 1 of 1)
510(K) Number: K99 1338
Device Name: Bovine Serum Albumin (BSA)
Indications for Use:
Bovine Serum Albumin ((BSA) is intended for those assisted reproductive procedures that require the use of a protein supplement. In particular, BSA is intended for use during in vitro fertilization, during in vitro embryo culture to the desired stage of embryo development, and for the cryopreservation of human embryos.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Rate Peller
(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological D 510(k) Number
Prescription Use __
(Per 21 CFR 801.109)